Cargando…
Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres
Radioembolization with (90)Y-loaded microspheres is increasingly used in the treatment of primary and secondary liver cancer. Technetium-99 m macroaggregated albumin (MAA) scintigraphy is used as a surrogate of microsphere distribution to assess lung or digestive shunting prior to therapy, based on...
Autores principales: | Garin, Etienne, Rolland, Yan, Laffont, Sophie, Edeline, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731431/ https://www.ncbi.nlm.nih.gov/pubmed/26338177 http://dx.doi.org/10.1007/s00259-015-3157-8 |
Ejemplares similares
-
Utility of Quantitative (99m)Tc-MAA SPECT/CT for (90)yttrium-Labelled Microsphere Treatment Planning: Calculating Vascularized Hepatic Volume and Dosimetric Approach
por: Garin, Etienne, et al.
Publicado: (2011) -
Factors modulating (99m)Tc‐MAA planar lung dosimetry for (90)Y radioembolization
por: Lopez, Benjamin P., et al.
Publicado: (2022) -
Erratum: “Factors modulating (99m)Tc‐MAA planar lung dosimetry for (90)Y radioembolization”
Publicado: (2023) -
Impact of the dosimetry approach on the resulting (90)Y radioembolization planned absorbed doses based on (99m)Tc-MAA SPECT-CT: is there agreement between dosimetry methods?
por: Morán, Verónica, et al.
Publicado: (2020) -
Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization
por: Lenoir, Laurence, et al.
Publicado: (2012)